[Electrocardiographic changes in acute organophosphate poisoning]

Cătălina Lionte1, L Sorodoc, O Petriş

  • 1Spitalul Clinic de Urgenţe "Sf. Ioan", Clinica Medicală, Facultatea de Medicină, Universitatea de Medicină si Farmacie "Gr.T. Popa", Iaşi.

Insights

Organophosphate poisoning can cause severe cardiac issues, including fatal arrhythmias and myocardial infarction. Early intensive care unit admission and monitoring are crucial for managing these serious cardiovascular complications.

Area of Science:

  • Toxicology
  • Cardiology
  • Emergency Medicine

Background:

  • Organophosphate (OP) poisoning is a significant global health concern, primarily known for its neurological effects.
  • Cardiac complications, though less understood, can be severe and fatal in OP poisoning.
  • Myocardial infarction is a rarely reported but serious cardiac event in acute pesticide poisoning.

Observation:

  • A 57-year-old woman ingested organophosphates, presenting with coma and non-cardiogenic pulmonary edema.
  • She experienced asystole, requiring resuscitation, and subsequent cardiac abnormalities including prolonged QTc, ST-T changes, right bundle branch block, and ventricular tachycardia.
  • The patient ultimately developed acute anteroseptal myocardial infarction and died despite normalized cholinesterase levels.

Findings:

  • Organophosphate exposure can lead to a spectrum of cardiac toxicity, including arrhythmias and conduction defects.
  • Acute myocardial infarction is a potential, albeit rare, complication of severe organophosphate poisoning.
  • Cardiac events may occur even after initial toxicological markers, like cholinesterase levels, normalize.

Implications:

  • Intensive care unit (ICU) admission is vital for patients with organophosphate poisoning.
  • Continuous electrocardiographic (ECG) and cardiac enzyme monitoring are essential for early diagnosis and management of cardiac complications.
  • Understanding the pathogenesis of OP-induced cardiotoxicity is critical for improving patient outcomes.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...